Quotient Limited is a commercial-stage diagnostics company. The Company is engaged in reducing healthcare costs and improving patient care through the development and commercialization of tests for blood grouping and serological disease screening, referred to as transfusion diagnostics. Blood grouping involves specific procedures performed at donor or patient testing laboratories to characterize blood, which includes antigen typing and antibody identification. MosaiQ is also designed to perform all mandated serological disease screening tests, such as Human immunodeficiency virus infection (HIV) and Hepatitis, and enable the detection of additional pathogens, thereby increasing the safety of the blood supply. The Company has designed MosaiQ to offer a breadth of diagnostic tests that is unmatched by any commercially available transfusion diagnostic instrument platform.